Stocks and Investing Stocks and Investing
Wed, April 10, 2019
Tue, April 9, 2019

John Newman Maintained (ALRN) at Strong Buy with Decreased Target to $100 on, Apr 9th, 2019


Published on 2024-10-26 12:59:08 - WOPRAI, John Newman
  Print publication without navigation


John Newman of Canaccord Genuity, Maintained "Aileron Therapeutics, Inc." (ALRN) at Strong Buy with Decreased Target from $380 to $100 on, Apr 9th, 2019.

John has made no other calls on ALRN in the last 4 months.



There is 1 other peer that has a rating on ALRN. Out of the 1 peers that are also analyzing ALRN, 0 agree with John's Rating of Hold.



This is the rating of the analyst that currently disagrees with John


  • Edward White of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $140 on, Monday, March 11th, 2019
Contributing Sources